Analysis of the state-of-the-art of consulting medical care to patients with glucocorticoid-induced osteoporosis or its risk according to the data of a questionnaire survey (GLUCOST study)
- 作者: Baranova IA1, Ershova OB1, Anaev EK.1, Anokhina TN1, Anoshenkova ОN1, Batyn SZ1, Belyaeva EA1, Bolshakova TY.1, Volkorezov IA1, Eliseeva LN1, Kashnazarova EV1, Kinyaikin MF1, Kirpikova MN1, Klyuchnikova EP1, Korolev MA1, Kuneevskaya IV1, Masneva LV1, Muradyants AA1, Otteva EN1, Petrachkova TN1, Peshekhonova LK1, Povzun AS1, Raskina TA1, Smirnova ML1, Toroptsova NV1, Khasanova RB1, Shamsutdinova NG1, Shaporova NL1, Shitova NS1, Shkireeva SY.1, Shostak NA1, Lesnyak OM1
-
隶属关系:
- 期: 卷 87, 编号 5 (2015)
- 页面: 58-64
- 栏目: Editorial
- ##submission.dateSubmitted##: 10.04.2020
- ##submission.datePublished##: 15.05.2015
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31746
- ID: 31746
如何引用文章
全文:
详细
作者简介
I Baranova
O Ershova
E Anaev
T Anokhina
О Anoshenkova
S Batyn
E Belyaeva
T Bolshakova
I Volkorezov
L Eliseeva
E Kashnazarova
M Kinyaikin
M Kirpikova
E Klyuchnikova
M Korolev
I Kuneevskaya
L Masneva
A Muradyants
E Otteva
T Petrachkova
L Peshekhonova
A Povzun
T Raskina
M Smirnova
N Toroptsova
R Khasanova
N Shamsutdinova
N Shaporova
N Shitova
S Shkireeva
N Shostak
O Lesnyak
参考
- Баранова И.А., Дыдыкина И.С. Глюкокортикоидный остеопороз. В кн: О.М.Лесняк, Л.И.Беневоленская. Остеопороз. Диагностика, профилактика и лечение. Клинические рекомендации. 2-е изд. М.: ГЭОТАР-Медиа; 2009:225-250.
- Sadat-Ali M, Alelq AH, Alshafei BA, Al-Turki HA, Abujubara MA. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Ann Saudi Med. 2009;29(3):215-218.
- Dolan AL, Koshy E, Waker M, Goble CM. Access to bone densitometry increases general practitioners’ prescribing for osteoporosis in steroid treated patients. Ann Rheum Dis. 2004;63(2):183-186.
- Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum. 2005;52(8):2485-2494.
- Ledwich LJ, Clarke K. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice. J Clin Rheumatol. 2009;15(2):61-64.
- Shah SK, Gecys GT. Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect. J Am Osteopath Assoc. 2006;106(11):653-657.
- Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ. Barriers in the management of glucocorticoid-induced osteoporosis. Arthritis Rheum. 2007;57(1):140-146.
- Баранова И.А., Ершова О.Б., Авдеева О.С. Оценка частоты и факторов риска низкоэнергетических переломов скелета по данным опроса больных хроническими воспалительными заболеваниями. Результаты многоцентрового исследования Российской ассоциации по остеопорозу ГЛЮКОСТ. Остеопороз и остеопатии. 2014;3:8-13.
- Лесняк О.М., Баранова И.А., Торопцова Н.В. Клинические рекомендации «Диагностика, профилактика и лечение глюкокортикоидного остеопороза у мужчин и женщин 18 лет и старше». Ярославль: Литера; 2014;48.
- Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC Jr, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR; AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9(6):544-564.
补充文件
![](/img/style/loading.gif)